Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 18, 2022
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
[ Mon, Jul 18th 2022
] - WOPRAI
Sat, July 16, 2022
[ Sat, Jul 16th 2022
] - WOPRAI
Fri, July 15, 2022
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
Matthew Harrison Maintained (BGNE) at Buy with Decreased Target to $293 on, Jul 15th, 2022
Matthew Harrison of Morgan Stanley, Maintained "BeiGene, Ltd." (BGNE) at Buy with Decreased Target from $300 to $293 on, Jul 15th, 2022.
Matthew has made no other calls on BGNE in the last 4 months.
There is 1 other peer that has a rating on BGNE. Out of the 1 peers that are also analyzing BGNE, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Berens of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $177 on, Thursday, March 17th, 2022
